Major paradigm shift incorporates five-year risk assessment and identifies increased-risk women beginning at age 35BOSTON, ...

The National Comprehensive Cancer Network ® (NCCN ®) - an alliance of leading cancer centers focusing on maintaining evidence-based expert consensus driven guidelines for care - announces the ...

Now, a significant update to the National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology is ...

Earlier this month, Corcept Therapeutics reported final Phase 3 ROSELLA data showing that Lifyorli (relacorilant) plus nab-paclitaxel improved overall and progression-free survival in adults with ...

PLYMOUTH MEETING, PA [October 6, 2025] — Today, the National Comprehensive Cancer Network ® (NCCN ®)—a nonprofit responsible for globally utilized guidelines for cancer care—is sharing new NCCN ...

Today, the National Comprehensive Cancer Network ® (NCCN ®)-a nonprofit responsible for globally utilized guidelines for cancer care-is sharing new NCCN Guidelines Navigator™ resources for breast ...

PLYMOUTH MEETING, PA [February 17, 2026] — The National Comprehensive Cancer Network ® (NCCN ®) today published new NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines ®) for Pediatric Soft ...

The NCCN has updated its guidelines on breast, pancreatic, colon, rectal, non-small cell lung, and other cancers. The National Comprehensive Cancer Network (NCCN) has updated its treatment guidelines ...

NCCN Guidelines® recommend FES PET for systemic staging in certain patients with invasive lobular cancer (ILC), which could facilitate greater diagnostic accuracy, earlier interventions, better ...

Dr. Lewis will succeed Dr. Denlinger who previously held the position of CSO before becoming CEO for the organization. Dr. Lewis will assume her new role in May 2026.